Abstract PR009: Application of Liquid Biopsy-RECIST (LB-RECIST) criteria to track metastatic colorectal cancer (mCRC) molecular response in first-line (1L) setting: Findings from the PLATFORM-B study
Year: 2024
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Valentino Martelli, Joana Vidal, Maria Concepción Fernández-Rodríguez, Pilar García-Alfonso, David Páez, Joan Gibert, Jennifer Linares, Annarita Sibilio, Vicente Alonso, Maria Teresa Cano, Cristina Santos, Gema Duran, Elena Élez, José Luis Manzano, Rocio Garcia-Carbonero, Reyes Ferreiro, Ferran Losa, Estela Pineda, Javier Sastre, Auxiliadora Gomez-España, Rodrigo Toledo, Fernando Rivera, Beatriz Bellosillo, Josep Tabernero, Ramon Ramon Salazar, Enrique Aranda, Clara Montagut
Institutions: Hospital Del Mar, Hospital del Mar Research Institute, Hospital General Universitario Gregorio Marañón, Hospital de Sant Pau, Hospital Universitario Miguel Servet, Hospital Universitario Reina Sofía, University of Córdoba, Institut Català d'Oncologia, Hospital Clínico Universitario Virgen de la Victoria, Vall d'Hebron Institute of Oncology, Hospital Universitari Germans Trias i Pujol, Hospital Universitario 12 De Octubre, Hospital Universitario Ramón y Cajal, Hospital de Sant Joan Despí Moisès Broggi, Hospital Clínic de Barcelona, Hospital Clínico San Carlos, Marqués de Valdecilla University Hospital
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4404305706